Bonofiglio L, Ojeda M I, de Mier C, Vay C, Famiglietti A, Gutkind G, Mollerach M
Cátedra de Microbiología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, 1113, Junín 956, Argentina.
Int J Antimicrob Agents. 2005 Mar;25(3):260-3. doi: 10.1016/j.ijantimicag.2004.10.011. Epub 2005 Jan 21.
Streptococcus pneumoniae isolates (n = 262) were recovered from adult patients with community-acquired pneumonia. Erythromycin-resistance levels increased from 9% (1997-1998) to 16% (2000-2002). Sampling for resistance mechanisms prevalent within 19 erythromycin-resistant S. pneumoniae showed mef(E) in 13/19 isolates while 4/19 carried the erm(B) gene (3/19 cMLS(B) and 1/19 iMLS(B) phenotype). MIC ranges for erythromycin and clindamycin were 0.5-16 mg/l and <0.008-0.063 mg/l for the M phenotype, 128-512 mg/l and 128-256 mg/l for the cMLS(B) phenotype, and 4 and <0.008 mg/l for the iMLS(B) phenotype. This is the first report studying the prevalence of macrolide resistance determinants in S. pneumoniae in our country.
从成年社区获得性肺炎患者中分离出262株肺炎链球菌。红霉素耐药率从1997 - 1998年的9%升至2000 - 2002年的16%。对19株红霉素耐药肺炎链球菌中普遍存在的耐药机制进行抽样检测,结果显示,19株中有13株携带mef(E)基因,4株携带erm(B)基因(3株为cMLS(B)表型,1株为iMLS(B)表型)。M表型的红霉素和克林霉素MIC范围分别为0.5 - 16mg/L和<0.008 - 0.063mg/L,cMLS(B)表型分别为128 - 512mg/L和128 - 256mg/L,iMLS(B)表型分别为4mg/L和<0.008mg/L。这是我国关于肺炎链球菌大环内酯类耐药决定因素流行情况的首次报道。